Shi, Liu et al. develop a SGLT-2i/GLP-1RA Decision Score to support personalized selection between the two therapies. The results show that the model achieved good predictive performance and offers a practical tool for optimizing SGLT-2i and GLP-1RA therapy decisions for patients with type 2 diabetes.
- Juan Shi
- Cong Liu
- Weiqing Wang